Disease-specific divergence of inflammatory and metabolic biomarkers in neurocritical neuromuscular disorders - Takeaways - MDSpire

Disease-specific divergence of inflammatory and metabolic biomarkers in neurocritical neuromuscular disorders

  • By

  • Sezgin Kehaya

  • Erdi Şensöz

  • May 13, 2026

  • 0 min

Share

  • 1

    Myasthenia gravis (MG) and Guillain–Barré syndrome (GBS) are autoimmune neuromuscular diseases requiring aggressive treatment and monitoring for respiratory failure.

  • 2

    Inflammatory indices like neutrophil-to-lymphocyte ratio (NLR) and systemic immune–inflammation index (SII) are significant in assessing disease severity in MG.

  • 3

    Lactate dehydrogenase (LDH) and its ratio to albumin (LAR) correlate with disease severity and respiratory involvement in MG patients.

  • 4

    In GBS, clinical outcomes are primarily influenced by neurological severity, with inflammatory indices showing limited prognostic significance.

  • 5

    Initial clinical severity is the most significant predictor of mechanical ventilation needs in both MG and GBS patients.

Original Source(s)

Disease-specific divergence of inflammatory and metabolic biomarkers in neurocritical neuromuscular disorders

  • by Sezgin Kehaya, Erdi Şensöz

  • May 13, 2026

Related Content

A Case Study and Literature Review on Type IV Spinal Muscular Atrophy with Gastrocnemius Pseudohypertrophy Due to SMN1 Gene Deletion

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.